These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4985767)

  • 1. Inactivation of human serum plasminogen antiactivator by synthetic fibrinolysis inducers.
    Aoki N; von Kaulla KN
    Thromb Diath Haemorrh; 1969 Nov; 22(2):251-62. PubMed ID: 4985767
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification and properties of an antiactivator fraction from bovine serum.
    Nanninga LB; Guest MM
    Thromb Haemost; 1979 Oct; 42(3):855-63. PubMed ID: 92070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human serum plasminogen antiactivator: its distinction from antiplasmin.
    Aoki N; Von Kaulla KN
    Am J Physiol; 1971 Apr; 220(4):1137-45. PubMed ID: 4251631
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic aspects of plasminogen.
    Sachs V; Szirmai E
    Angiology; 1970 Jan; 21(1):1-4. PubMed ID: 4984359
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the antifibrinolytic activity of the esters of 4-aminomethylbenzoic acid (PAMBA)].
    Markwardt F; Neuland P; Klöcking HP
    Pharmazie; 1966 Jun; 21(6):345-8. PubMed ID: 6000982
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between the inhibition of ATPase activity and inflammatory edema by nonsteroid anti-inflammatory drugs. Approach to the screening test in vitro of nonsteroid anti-inflammatory drugs].
    Aizawa Y; Iwasaki M
    Nihon Yakurigaku Zasshi; 1970 Jul; 66(4):394-9. PubMed ID: 4250435
    [No Abstract]   [Full Text] [Related]  

  • 7. The binding of diiodosalicylate and flufenamate to the plasma antiactivator: analysis of chemical fibrinolysis.
    Nanninga LB
    Thromb Haemost; 1979 Apr; 41(2):357-64. PubMed ID: 572998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogenic treatment of prostatic cancer lowers the fibrinolytic activity in vein walls.
    Carlsson S; Astedt B
    Scand J Urol Nephrol; 1974; 8(3):169-72. PubMed ID: 4139751
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural inhibitors of fibrinolysis.
    Aoki N
    Prog Cardiovasc Dis; 1979; 21(4):267-86. PubMed ID: 154122
    [No Abstract]   [Full Text] [Related]  

  • 10. Antifibrinolytic effect of Apernyl in "dry socket".
    Birn H
    Int J Oral Surg; 1972; 1(4):190-4. PubMed ID: 4199167
    [No Abstract]   [Full Text] [Related]  

  • 11. Human coumarin prothrombin. Chromatographic, coagulation and immunologic studies.
    Cesbron N; Boyer C; Guillin MC; Ménaché D
    Thromb Diath Haemorrh; 1973 Dec; 30(3):437-50. PubMed ID: 4207085
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhibitor of fibrinolysis from pancreas pantrypin].
    Lakin KM; Efimov VS; Polonskaia LB
    Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of venous occlusion on coagulation and fibrinolytic components in normal subjects.
    Nilsson IM; Robertson B
    Thromb Diath Haemorrh; 1968 Dec; 20(3):397-408. PubMed ID: 5710462
    [No Abstract]   [Full Text] [Related]  

  • 14. [Method for the determination of fibrinolytic activity of plasma euglobulin fraction and of antifibrinolytic activity of blood serum].
    Aslanian NL; Shukhian VM
    Lab Delo; 1971; 6():329-31. PubMed ID: 4108742
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antifibrinolytic effect of araliphatic esters and amides of p-aminomethylbenzoic acid].
    Klöcking HP; Knauer H; Markwardt F
    Acta Biol Med Ger; 1973; 30(3):Suppl:K9-13. PubMed ID: 4762328
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of some synthetic compounds on in vitro fibrinolytic activity measured by different methods and the relevance to activity in vivo.
    Baillie AJ; Sim AK
    Thromb Diath Haemorrh; 1972 Dec; 28(3):351-8. PubMed ID: 4265316
    [No Abstract]   [Full Text] [Related]  

  • 18. The antigenic heterogenity of M protein of Streptococcus pyogenes (type 24).
    Havlícek J; Alouf JE; Raynaud M
    Zentralbl Bakteriol Orig; 1970; 214(3):390-2. PubMed ID: 4994145
    [No Abstract]   [Full Text] [Related]  

  • 19. [p-Aminomethylbenzoic acid ethylester--an effective oral antifibrinolytic agent].
    Klöcking HP
    Z Arztl Fortbild (Jena); 1967 Sep; 61(17):880-2. PubMed ID: 5589350
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.